Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL16194992

CC1(C)CCC(NCCOc2ccc(-c3ccc(-c4ncc[nH]4)cc3)cc2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP19A1 P11511 1/20 0.46
CYP2C9 P11712 1/20 0.46
ALDH1A1 P00352 6/20 0.44
KDM4E B2RXH2 7/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KCNH2 Q12809 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
FASN P49327 1/20 0.39
MCHR1 Q99705 1/20 0.38
RARB P10826 1/20 0.37
RARG P13631 1/20 0.37
HTR5A P47898 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3343094 0.93 ALDH1A1 (0.45) CYP1A2CYP2D6CYP2C19CYP3A4CYP19A1
SCHEMBL12651501 0.91 CYP1A2 (0.54) CYP1A2CYP2D6CYP2C19CYP3A4CYP19A1
SCHEMBL12651500 0.83 CYP1A2 (0.46) CYP1A2CYP2D6CYP2C19CYP3A4CYP19A1
Trifluoroacetic Acid SCHEMBL3042666 0.82 ALDH1A1 (0.42) CYP1A2CYP2D6CYP2C19ALDH1A1KDM4E
Trifluoroacetic Acid SCHEMBL1790344 0.82 ALDH1A1 (0.47) CYP1A2CYP2D6CYP2C19ALDH1A1KDM4E
Trifluoroacetic Acid SCHEMBL3346088 0.81 RAD52 (0.40) ALDH1A1KDM4EKCNH2FASNHTR5A
Trifluoroacetic Acid SCHEMBL3340019 0.79 SLC2A1 (0.41) MEN1KMT2AFASNHTR5A
SCHEMBL16194993 0.78 CYP1A2 (0.44) CYP1A2CYP2D6CYP2C19CYP3A4CYP19A1
Trifluoroacetic Acid SCHEMBL3340376 0.77 ALDH1A1 (0.47) ALDH1A1KDM4EMEN1KMT2ARARB
Trifluoroacetic Acid SCHEMBL3340913 0.76 ALDH1A1 (0.44) CYP1A2CYP2D6CYP2C19ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140323487-A1 Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors GLAXOSMITHKLINE LLC 2014-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140323487-A1 Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors OPRL1, OPRM1, OPRK1 CYP1A2 2005/4885CYP2D6 1435/4885CYP2C19 2309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.